Results 21 to 30 of about 4,539 (178)

Perforating scleral vessels adjacent to myopic choroidal neovascularization achieved a poor outcome after intravitreal anti-VEGF therapy. [PDF]

Front Med (Lausanne), 2022
Yao W, Xu J, She X, Yu J, Liang Z, Ye X, Tao J, Wu S, Mao J, Chen Y, Zhang Y, Shen L.   +11 more
europepmc   +2 more sources

Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization [PDF]

Scientific Reports, 2018
The authors performed a retrospective and comparative study to compare the efficacy of intravitreal aflibercept and bevacizumab for patients with myopic choroidal neovascularization (mCNV).
Jia-Kang Wang, Tzu-Lun Huang, Pei-Yao Chang, Yen-Ting Chen, Chin-Wei Chang, Fang-Ting Chen, Yung-Ray Hsu, Yun-Ju Chen   +7 more
doaj   +2 more sources

Optical coherence tomography biomarkers for myopic choroidal neovascularization treated with anti-vascular endothelial growth factor. [PDF]

Kaohsiung J Med Sci, 2023
Lee DY, Wu PY, Sheu SJ.
europepmc   +3 more sources

Ten-Year Outcomes of Intravitreal Bevacizumab for Myopic Choroidal Neovascularization: Analysis of Prognostic Factors. [PDF]

Pharmaceuticals (Basel), 2021
Mallone F, Giustolisi R, Franzone F, Marenco M, Plateroti R, Nebbioso M, Lambiase A, Gharbiya M.   +7 more
europepmc   +3 more sources

Myopia and Inflammation [PDF]

Journal of Ophthalmic & Vision Research, 2011
The correlation between myopia and intraocular inflammation has rarely been explored. The aim of this article is to review myopic changes induced by inflammatory diseases and inflammatory diseases related to myopia, followed by a discussion on ...
Carl P Herbort, Marina Papadia, Piergiorgio Neri   +2 more
doaj   +3 more sources

Morphological parameters of myopic choroidal neovascularization as predictive factors of anti-VEGF treatment response. [PDF]

Sci Rep, 2022
Castellino N, Battaglia Parodi M, Russo A, Toro MD, Fallico M, Bonfiglio V, Maugeri AD, Avitabile T, Longo A.   +8 more
europepmc   +3 more sources

Optical coherence tomography Angio-B mode for early detection of myopic choroidal neovascularization and treatment with Bevacizumab. [PDF]

Am J Ophthalmol Case Rep
Rico S, Sher I, Lavinsky F, Lavinsky D, Rotenstreich Y.   +4 more
europepmc   +2 more sources

Macular density alterations in myopic choroidal neovascularization and the effect of anti-VEGF on it. [PDF]

Int J Ophthalmol, 2021
Mao JB, Shao YR, Yu JF, Deng XY, Liu CY, Chen YQ, Zhang Y, Xu ZK, Wu SL, Shen LJ.   +9 more
europepmc   +2 more sources

Choroidal Vascular Density Quantification in High Myopia with or without Choroidal Neovascularization Using Optical Coherence Tomography Angiography

Journal of Ophthalmology, 2023
Purpose. The aim of this study was to analyze choroidal vascular density alteration in high myopia with or without choroidal neovascularization by using optical coherence tomography angiography (OCTA). Methods.
Xuehui Lu, Guihua Zhang, Lingping Cen, Yali Du, Lifang Liu, Chuang Jin, Haoyu Chen   +6 more
doaj   +1 more source

Comparison of Intravitreal Aflibercept and Ranibizumab for Treatment of Myopic Choroidal Neovascularization: One-Year Results-A Retrospective, Comparative Study. [PDF]

J Ophthalmol, 2019
Erden B, Bölükbaşı S, Baş E, Çakır A.   +3 more
europepmc   +3 more sources